Rekah Pharmaceutical Prod Ltd. Logo

Rekah Pharmaceutical Prod Ltd.

A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.

REKA | TA

Overview

Corporate Details

ISIN(s):
IL0010810096
LEI:
Country:
Israel
Address:
Hamelaha 30, 5881904 Holon
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rekah Pharmaceutical Prod Ltd. is a generic pharmaceuticals manufacturer with over 70 years of industry experience. The company is active across the entire value chain, from research and development to production, marketing, sales, distribution, import, and export. Its portfolio features over 400 registered products, including generic prescription (Rx) and over-the-counter (OTC) drugs, medical devices, dermo-cosmetics, vitamins, and nutritional supplements. Rekah has in-depth expertise in specific therapeutic categories, specializing in the manufacturing of steroidal tablets, antibiotics, and ophthalmic products. The company focuses on expanding its international footprint through strategic collaborations, co-development partnerships, and licensing agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Rekah Pharmaceutical Prod Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Rekah Pharmaceutical Prod Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Rekah Pharmaceutical Prod Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel KMDA
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547

Talk to a Data Expert

Have a question? We'll get back to you promptly.